HOME >> BIOLOGY >> NEWS
Discovery Of Mechanism Causing Colon Cancer

REHOVOT, Israel - May 11, 1999 -WeizmannInstitute researchers have discovered a molecular mechanism that may be involved in causing colon cancer,according to a study reported in the May 11 issue of the Proceedings of the National Academy of Sciences.

This research may one day contribute to the development of potential therapies for this type of malignancy and possibly for other types of cancer as well.

The discovery of the new mechanism has solved two seemingly unrelated molecular mysteries.

One concerned an important finding made some two years ago: the fact that colon cancer cells often have abnormally large quantities of a protein called beta- catenin, one of today's "hottest" research molecules. Beta-catenin has been dubbed a"moonlighter" because it holds down two distinct cellular jobs. In its better-known task, beta-catenin binds to adhesion molecules - those molecules that sit in the cellular membrane and allow cells to stick together. In its other role, beta-catenin is known to regulate the performance of genes in the nucleus. However, how exactly beta-catenin does this - and which genes it controls - remained unclear.

The second molecular mystery centered around the gene cyclin D1 - a major regulator of cell growth which, when mutated, can act as an oncogene, or gene that causes cancer. The levels of the protein produced by this gene are abnormally high in about 30 percent of colon cancers, indicating that cyclin D1 may be involved in malignant transformation. However, the cyclin D1 gene found in colon cancer cells is perfectly normal. This baffled researchers because usually oncogenes cause cancer only when they appear in mutated form.

A team of researchers led by Prof. Avri Ben-Ze'ev of the Weizmann Institute's Molecular Cell Biology Department, in collaboration with the group of Dr. Richard Pestell from the Albert Einstein College of Medicine in New York, has now put these two mysterious puzzle pieces together
'"/>

Contact: Arthur Berger, VP Public Policy & Marketing
arthur@acwis.org
212-779-2500, Ext. 1
American Committee for the Weizmann Institute of Science
11-May-1999


Page: 1 2 3

Related biology news :

1. Discovery of new shrimp species adds to unique family
2. Discovery of tiny microbes in ancient Greenland glacier may define limits for life on Earth
3. Discovery in parasite movement may offer insights into malaria
4. Scientists find second way to kill cancer cells: Discovery opens possibilities for new therapies
5. GlaxoSmithKline Drug Discovery and Development Research Grant Program 2004
6. Discovery helps explain how cells package DNA
7. Discovery offers clues to origin of life
8. Discovery could improve anemia treatment in patients
9. Discovery could lead to better treatment for cryptosporidum infections
10. Discovery of brain disorder gene paves way for genetic test
11. Discovery may be first plant cell surface molecule that halts cell proliferation

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Discovery Mechanism Causing Colon Cancer

(Date:6/18/2013)... -- Paris Air Show – Marvin Test Solutions ... leading provider of innovative test solutions for military ... this week at the Paris Air Show ... increasingly complex armament systems with longer lifecycles, industry ... solutions that address legacy system obsolescence. Marvin Test ...
(Date:6/18/2013)... Brandeis University, sophisticated computational models and advances in ... complex interplay between genomic data, virus structure and ... critical for replication. , "We hope ... help researchers alter virus assembly, leaving viruses unable ... author of the scientific paper describing the technique, ...
(Date:6/18/2013)... 18, 2013 Joshua Obar, Ph.D., Department of Immunology ... with a 2013 ICAAC Young Investigator Award for his ... memory responses to infection. , Obar earned his ... and went on to complete his Ph.D. in Microbiology ... performed his Ph.D. thesis research in Edward Usherwood,s laboratory ...
Breaking Biology News(10 mins):Marvin Test Solutions Demonstrates Next-Generation Armament Test Solutions at Paris Air Show 2Marvin Test Solutions Demonstrates Next-Generation Armament Test Solutions at Paris Air Show 3Computer modeling technique goes viral at Brandeis 2The American Society for Microbiology honors Joshua Obar 2
(Date:6/20/2013)... (PRWEB) June 20, 2013 Conscires offer ... levels of interests and budgets., , ... on Scrum basics and the ScrumMaster role. In addition ... group activities and discussions on the necessary soft skills ... Scrum Team, and company-oriented Scrum implementation aspects. , ...
(Date:6/19/2013)... , June 19, 2013  U.S. Secretary of State ... at which distinguished Syngenta  scientist Mary-Dell Chilton ... 2013 World Food Prize. The prize is the foremost ... by improving the quality, quantity or availability of food ... other laureates were recognized for "revolutionary biotechnology discoveries that ...
(Date:6/19/2013)... -- Continuing its long history of proven clinical performance in ... Inc. announces the U.S. Food and Drug Administration (FDA) ... assay for use on its Access 2 immunoassay system. ... Coulter,s troponin I test for over 12 years ... to continue providing dependability to laboratories supporting emergency care," ...
(Date:6/19/2013)... , June 19, 2013 /PRNewswire/ ... Bureau presents Innovative Drug Delivery ... Technology Licensing Opportunities for Generic ... There are more ... release drugs approved all over ...
Breaking Biology Technology:Presenting Agile and Scrum Private Trainings in Kansas by Conscires Agile Practices 2Syngenta's Mary-Dell Chilton named 2013 World Food Prize laureate 2Beckman Coulter Announces FDA Clearance of New Access AccuTnI+3 Troponin I Assay for the Access 2 Immunoassay System 2Beckman Coulter Announces FDA Clearance of New Access AccuTnI+3 Troponin I Assay for the Access 2 Immunoassay System 3Innovative Drug Delivery Systems: Novel Product and Formulation Technology Licensing Opportunities for Generic Pharmaceutical Companies 2Innovative Drug Delivery Systems: Novel Product and Formulation Technology Licensing Opportunities for Generic Pharmaceutical Companies 3
Cached News: